ClinicalTrials.Veeva

Menu

New Needle for Two-Needle Hemodialysis (BME-1)

B

BioMedical Enterprises

Status and phase

Unknown
Phase 3
Phase 2

Conditions

End Stage Renal Disease

Treatments

Procedure: Hemodialysis using a new venous needle, the "BME needle"
Procedure: Hemodialysis using the standard venous needle

Study type

Interventional

Funder types

Industry
NIH

Identifiers

NCT01416896
R44DK059062 (U.S. NIH Grant/Contract)
BME-1

Details and patient eligibility

About

Our preliminary studies have demonstrated that an innovative new design of the hemodialysis venous needle (the needle that returns the cleaned blood from the hemodialysis filter to the patient) with three jets is superior to the standard venous needle because it decreases the velocity and turbulence of the blood when compared with the standard venous needle, it is more efficient in the removal of toxins from the blood, and it is safe and effective. More importantly, our preliminary studies suggested that the new needle causes less damage to the dialysis vascular access and to circulating blood cells and less inflammation and oxidative stress. These will decrease medical complications, the high cost of care and death in dialysis patients. The current study will corroborate the finding of previous studies.

Enrollment

70 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:(1) end stage renal disease receiving hemodialysis in an ambulatory outpatient dialysis facility (2) male or female, (3) ages 18-80, (4) arterio-venous graft or AV fistula as vascular access,

Exclusion Criteria:patients with fever, infection, inflammation or malignancy will be excluded

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

70 participants in 2 patient groups

New venous needle, the "BME needle"
Experimental group
Description:
Hemodialysis using the new venous needle, the "BME needle".
Treatment:
Procedure: Hemodialysis using a new venous needle, the "BME needle"
Procedure: Hemodialysis using a new venous needle, the "BME needle"
Standard venous needle, the "standard needle"
Active Comparator group
Description:
One hemodialysis using the standard venous needle, the "standard needle" (device).
Treatment:
Procedure: Hemodialysis using the standard venous needle
Procedure: Hemodialysis using the standard venous needle

Trial contacts and locations

1

Loading...

Central trial contact

Pedro A Jose, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems